Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycemic trajectory after face-to-face diabetes self-management education: a dose-response meta-analysis.

Diabetes research and clinical practice·2026
Same author

Repositioning for pressure injury prevention in adults.

The Cochrane database of systematic reviews·2026
Same author

A comparison of frequentist and Bayesian methods for meta-analysis of diagnostic test accuracy studies.

Epidemiology and infection·2026
Same author

Six Entrenched Misconceptions About Meta-Analysis Models.

Journal of evidence-based medicine·2026
Same author

Diagnostic Accuracy of Multiplex NAAT/PCR and Culture Against <i>Salmonella</i> spp.: A Comparison of Meta-Analytical Methods.

Pathogens (Basel, Switzerland)·2026
Same author

Bias-adjusted meta-analysis using the quality effects model: a Stata tutorial.

JBI evidence synthesis·2026

Related Experiment Videos

A quality-effects model for meta-analysis.

Suhail A R Doi1, Lukman Thalib

  • 1Division of Endocrinology, Mubarak Al-Kabeer Teaching Hospital, Kuwait University, Kuwait. sardoi@gmx.net

Epidemiology (Cambridge, Mass.)
|December 20, 2007
PubMed
Summary

We present a new quality-effects approach for combining trial evidence, accounting for methodological differences. This method offers a potentially more convincing alternative to the standard random-effects model for analyzing intervention efficacy.

Related Experiment Videos

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Evidence Synthesis

Background:

  • Combining evidence from multiple clinical trials is crucial for assessing intervention efficacy.
  • Existing methods like the random-effects model address between-trial heterogeneity but may not fully capture study quality variations.
  • Methodological differences between studies can significantly impact the reliability of combined results.

Purpose of the Study:

  • To introduce a novel quality-effects approach for synthesizing evidence from comparative intervention trials.
  • To incorporate measured methodological heterogeneity into the analysis of overall interventional efficacy.
  • To propose a practical and convincing alternative to the random-effects model.

Main Methods:

  • Developed a quality-effects approach integrating evidence from multiple comparative trials.
  • Incorporated measured methodological heterogeneity between studies into the analytical framework.
  • Proposed a simple, noniterative procedure for calculating the combined effect size.

Main Results:

  • The quality-effects approach accounts for heterogeneity of effects in efficacy analysis.
  • Adjustment is based on measured methodological heterogeneity, differing from random-effects models.
  • A straightforward computational procedure for the combined effect size is provided.

Conclusions:

  • The proposed quality-effects approach offers a robust method for evidence synthesis.
  • This approach provides a potentially more convincing alternative to the random-effects model.
  • It emphasizes the importance of methodological quality in combining intervention trial results.